Mieke Van Hemelrijck, Professor in Cancer Epidemiology at King’s College London, shared a post on LinkedIn:
“While TOUR: Transforming Cancer Outcomes through Research member Louis Fox is heading to ESMO to present our collaborative work with the EORTC – European Organisation for Research and Treatment of Cancer on quality of life in cancer patients receiving immune checkpoint inhibitors, I’m in Uppsala for the SPCG-17/PCASTt Steering Committee meeting.
The agenda is packed with important discussions, including finalizing the Statistical Analysis Plan (SAP) and reviewing supplemental power calculations.
Looking forward to a day of collaboration and progress in prostate cancer research!”
More posts featuring Mieke Van Hemelrijck on OncoDaily.
